BioAdaptives, Inc.
$0.01+0.00%(+$0.00)
TickerSpark Score
50/100
67
Valuation
60
Profitability
55
Growth
36
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BDPT research report →
52-Week Range4% of range
Low $0.01
Current $0.01
High $0.09
Companywww.shopbioadaptives.com
BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. The company focuses on offering health and wellness products, such as dietary supplements.
- CEO
- James E. Keener
- IPO
- 2014
- Employees
- 1
- HQ
- Las Vegas, NV, US
Price Chart
-78.00% · this period
Valuation
- Market Cap
- $100.53K
- P/E
- -0.09
- P/S
- 4.23
- P/B
- -0.06
- EV/EBITDA
- -0.34
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 60.36%
- Op Margin
- -4159.98%
- Net Margin
- -6186.89%
- ROE
- 85.75%
- ROIC
- 58.92%
Growth & Income
- Revenue
- $18.28K · 44.27%
- Net Income
- $-1,557,898 · -73.29%
- EPS
- $-0.15 · -36.36%
- Op Income
- $-1,042,173
- FCF YoY
- -114.02%
Performance & Tape
- 52W High
- $0.09
- 52W Low
- $0.01
- 50D MA
- $0.02
- 200D MA
- $0.04
- Beta
- 1.44
- Avg Volume
- 49.61K
Get TickerSpark's AI analysis on BDPT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 1, 26 | FRISSORA MARK P | other | 4,808 |
| Apr 1, 26 | FRISSORA MARK P | other | 4,386 |
| Mar 1, 26 | FRISSORA MARK P | other | 2,578 |
| Feb 1, 26 | FRISSORA MARK P | other | 2,565 |
| Jan 1, 26 | FRISSORA MARK P | other | 2,286 |
| Dec 1, 25 | FRISSORA MARK P | other | 2,025 |
| Nov 1, 25 | FRISSORA MARK P | other | 1,382 |
| Oct 1, 25 | FRISSORA MARK P | other | 1,517 |
| Sep 1, 25 | FRISSORA MARK P | other | 1,506 |
| Aug 1, 25 | FRISSORA MARK P | other | 1,307 |
Our BDPT Coverage
We haven't published any research on BDPT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BDPT Report →